INMUNE BIO INC (INMB:NASDAQ)
$1.4 -0.03 (-2.0979%)
Analysed INMUNE BIO INC (INMB:NASDAQ) News Sources
INmune Bio (NASDAQ:INMB) Will Have To Spend Its Cash Wisely
01-04-2026
yahoo.com
INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
16-04-2026
yahoo.com
INmune Bio Inc. to Report First Quarter 2026 Financial Results and Provide Corporate Update on Thursday, May 7th
30-04-2026
yahoo.com
INmune Bio and Anthony Nolan Announce Strategic Expansion of CORDStrom™ MSC Platform Collaboration to Target RDEB, Oncology, and Inflammatory Diseases
05-05-2026
yahoo.com
INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
07-05-2026
yahoo.com
INmune Bio, Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
INmune Bio (INMB) Q1 2026 Earnings Transcript
08-05-2026
fool.com
INmune Bio Named Founding Member of the American Biotech Innovation Alliance (ABIA) as U.S. Biotech Sector Navigates Strategic Inflection Point
13-05-2026
yahoo.com
INmune Bio Receives FDA Fast Track Designation for XPro1595 in Early Alzheimer's Disease
14-05-2026
yahoo.com
INmune Bio Publishes Phase 2 MINDFuL Trial Results in NPJ Dementia, Advancing the XPro™ Platform
15-05-2026
yahoo.com
What is the current price of INMUNE BIO INC (INMB:NASDAQ)?
The current price of INMUNE BIO INC (INMB:NASDAQ) is $1.4.
INMUNE BIO INC (INMB:NASDAQ) absolute price change since previous trading day?
The absolute price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is $-0.03.
INMUNE BIO INC (INMB:NASDAQ) percentage price change since previous trading day?
The percentage price change of INMUNE BIO INC (INMB:NASDAQ) since the previous trading day is -2.0979%.
What is the most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ)?
The most recent average sentiment score for INMUNE BIO INC (INMB:NASDAQ) is 59 out of 100.
What is the most recent average sentiment for INMUNE BIO INC (INMB:NASDAQ)?
The most recent sentiment for INMUNE BIO INC (INMB:NASDAQ) is .
SEC-8K** Filing Available For INMUNE BIO INC (INMB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.